Immune-mediated destruction of cholangiocytes in diseases including primary biliary cirrhosis (PBC), allograft rejection and graft versus host disease occurs as a result of increased apoptosis, mediated by activation of tumour necrosis factor receptor family members (TNFr) [1]. The gene discussed is TNFRSF1A; the disease is primary biliary cholangitis.